Teladoc Health
TDOC
743 hedge funds and large institutions have $16.6B invested in Teladoc Health in 2020 Q3 according to their latest regulatory filings, with 167 funds opening new positions, 300 increasing their positions, 201 reducing their positions, and 86 closing their positions.
94% more first-time investments, than exits
New positions opened: 167 | Existing positions closed: 86
49% more repeat investments, than reductions
Existing positions increased: 300 | Existing positions reduced: 201
31% more funds holding in top 10
Funds holding in top 10: 13 → 17 (+4)
21% more capital invested
Capital invested by funds: $13.7B → $16.6B (+$2.89B)
11% more funds holding
Funds holding: 669 → 743 (+74)
2.97% less ownership
Funds ownership: 96.11% → 93.15% (-3%)
16% less call options, than puts
Call options by funds: $940M | Put options by funds: $1.13B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$484M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$398M |
| 3 |
DVF
Discovery Value Fund
Singapore
|
+$306M |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$198M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$193M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$136M |
| 2 |
BlackRock
New York
|
-$134M |
| 3 |
Millennium Management
New York
|
-$120M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$119M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$117M |
TDOC Hedge Fund Activity: Q3 2020 in Review
743 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q3 2020, worth a combined $16.6B — up 21% from $13.7B a quarter earlier.
Buyers outnumbered sellers: 167 funds opened new TDOC positions and 86 closed out — a net gain of 81 holders — while 300 added to existing stakes and 201 trimmed.
The largest buyer was Jennison Associates, adding an estimated $484M. The largest seller was Goldman Sachs, cutting an estimated $136M.
- 743 institutional investors held Teladoc Health (TDOC) as of Q3 2020, up from 669 in Q2 2020.
- Funds reported $16.6B of Teladoc Health stock for Q3 2020, up 21% quarter-over-quarter.
- 167 funds opened new Teladoc Health positions in Q3 2020 and 86 closed out, a net change of +81 holders.
- The largest Teladoc Health buyer in Q3 2020 was Jennison Associates, an estimated $484M added.
- The largest Teladoc Health seller in Q3 2020 was Goldman Sachs, an estimated $136M sold.
Based on aggregated 13F filings for Q3 2020.